Endocardial cells form the inner endothelial layer of the heart tube, surrounded by the myocardium. Signaling pathways that regulate endocardial cell specification and differentiation are largely unknown and the origin of endocardial progenitors is still being debated. To study pathways that regulate endocardial differentiation in a zebrafish model system, we isolated zebrafish NFATc1 homolog which is expressed in endocardial but not vascular endothelial cells. We further demonstrate that Hedgehog (Hh) but not VegfA or Notch signaling is required for early endocardial morphogenesis. Pharmacological inhibition of Hh signaling with cyclopamine treatment resulted in nearly complete loss of the endocardial marker expression. Simultaneous knockdown of the two zebrafish sonic hedgehog homologs, shh and twhh or Hh co-receptor smoothened (smo) resulted in similar defects in endocardial morphogenesis. Inhibition of Hh signaling resulted in the loss of fibronectin (fn1) expression in the presumptive endocardial progenitors as early as the 10-somite stage which suggests that Hh signaling is required for the earliest stages of endocardial specification. We further show that the endoderm plays a critical role in migration but not specification or differentiation of the endocardial progenitors while notochord-derived Hh is a likely source for the specification and differentiation signal. Mosaic analysis using cell transplantation shows that Smo function is required cell-autonomously within endocardial progenitor cells. Our results argue that Hh provides a critical signal to induce the specification and differentiation of endocardial progenitors.
Introduction

Specification of endocardium
The heart is composed of diverse muscle and non-muscle cell lineages: atrial/ventricular cardiac myocytes, conduction system cells, smooth muscle/endothelial cells of the coronary arteries and veins, endocardial cells, valvular components and connective tissue (Laugwitz et al., 2008) . During cardiogenesis, the differentiation of these multiple heart lineages is under tight spatial and temporal control, resulting in the coordinated formation of the distinct tissue components of the heart (Brand, 2003; Harvey, 2002) . Although significant progress has been made towards elucidating the morphogenetic events and transcriptional control underlying the patterning of the myocardium, the morphogenetic events and transcription factors involved in early development of the endocardium remain largely undefined. In fact, the origins of endocardial cells are still debated (Harris and Black, 2010; Lough and Sugi, 2000) .
Previous studies using largely in vitro cell culture models have suggested that endocardial cells represent a distinct endothelial lineage and have implicated BMP, Wnt, Gata5 and NFATc1 function in regulating endocardial differentiation (Misfeldt et al., 2009; Nemer and Nemer, 2002) . Vascular endothelial and endocardial cells share expression of multiple markers including cdh5, fli1, kdrl and tie2 (Brown et al., 2000; Larson et al., 2004; Lyons et al., 1998; Sumanas et al., 2005; Thompson et al., 1998) . Very few known molecular markers are specific to endocardium; one of them is nuclear factor of activated T-cells, cytoplasmic, calcineurindependent 1 (NFATc1), which is expressed in the mouse endocardial but not vascular endothelial cells indicating that the two endothelial subtypes are biochemically distinct (de la Pompa et al., 1998) .
Zebrafish has emerged as an advantageous model system for early development and cardiac specification. Similar to other vertebrates, zebrafish endocardial and myocardial precursors originate in the bilateral adjacent regions within the anterior lateral plate mesoderm (ALPM) during the early somitogenesis stages. Based on fate mapping experiments in zebrafish, the rostral ALPM region, in addition to the endocardial progenitors, also gives rise to the vascular endothelial and myeloid cells . While NFATc homologs have not been previously characterized in zebrafish, early endocardial precursors can be observed by analyzing the expression of vascular Developmental Biology 361 (2012) [377] [378] [379] [380] [381] [382] [383] [384] [385] [386] [387] [388] [389] [390] [391] endothelial markers such as cdh5, fli1, flk1/kdrl and tie2 that mark both endocardial and endothelial cell populations. Endocardial precursors can be distinguished from other vascular endothelial cells as they migrate towards the midline and posteriorly and fuse between the 15-18 somite stages (Bussmann et al., 2007) . Subsequently, they undergo a complex leftward movement to position endocardial primordium at the left side of the embryo between the 22-26 somite stages. At this point, endocardial cells become positioned next to the myocardial precursors and form the lining of the primitive heart tube. Signaling pathways involved in any of these steps during endocardium formation in vivo are currently largely unknown.
Endoderm has been previously implicated in cardiac induction (Lough and Sugi, 2000) . Zebrafish endodermal mutants such as cas/ sox32 display cardiac bifida as myocardial precursors remain positioned bilaterally and fail to migrate to the midline (Alexander et al., 1999; Kupperman et al., 2000) . Kdrl and fli1-expressing presumptive endocardial precursors remain positioned bilaterally and do not migrate towards the midline in cas mutant embryos (Holtzman et al., 2007) . However, the molecular nature of the endodermal derived signal is not known. It is also unclear if endoderm plays a direct role in initiating the migration of endocardial precursors and if it is also required for their differentiation.
Fibronectin (fn1) is thought to be one of the earliest markers for endocardial precursors in mammalian embryos and zebrafish (Palencia-Desai et al., 2011; Suzuki et al., 1995; Trinh and Stainier, 2004) . Natter/fn1 homozygous mutant zebrafish embryos display defects in cardiac fusion and defects in the endocardial sheet formation (Garavito-Aguilar et al., 2010; Trinh and Stainier, 2004) . Its function is required for the migration of myocardial precursors in zebrafish. In mouse, Fn mutants display multiple defects in cardiac formation although the initial endocardial specification appears to proceed normally (George et al., 1997) . However, it is not known whether Fn function is required for endocardial differentiation.
Vegf, Hh and Notch signaling pathways have been previously implicated in multiple aspects of endothelial cell differentiation including endothelial progenitor migration, vessel branching and arterial-venous differentiation (Ellertsdottir et al., 2010) . However, their role in endocardial specification and differentiation has not been previously analyzed. Hh signaling, in particular, has been implicated in multiple processes during development. Following modification with cholesterol and palmitate (Mann and Beachy, 2004) , Hh ligands are released from the producing cells. Hh ligands form a morphogen gradient and the signal is transduced by the receptor Patched (Ptc) and co-receptor Smoothened (Smo) (Cohen, 2003; Nagase et al., 2007) . Hh binding to Ptc relieves Ptc-mediated repression of Smo leading to activation of downstream Gli transcription factors in vertebrates. The steroidal alkaloid cyclopamine (CyA) is a natural antagonist of Hh signaling by influencing the balance between the active and inactive forms of the Smo protein (Chen et al., 2002) . In vertebrates there are three homologues of Drosophila Hh, Sonic Hedgehog (Shh), Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh). Due to partial genome duplication in zebrafish, there are two homologs for Shh (Shh and Tiggy-winkle Hedgehog, Twhh) and Ihh (Ihha and Echidna Hedgehog, Ehh/Ihhb) (Avaron et al., 2006; Currie and Ingham, 1996; Ekker et al., 1995; Krauss et al., 1993) . Shh expression pattern during early zebrafish development includes the notochord, the floor plate and the endoderm while twhh expression is restricted to the floor plate (Ekker et al., 1995; Reichenbach et al., 2008) . Ehh/Ihhb expression is restricted to the notochord (Currie and Ingham, 1996) while Ihha and Dhh expression has been reported only in the cartilage precursors (Avaron et al., 2006) .
Hh signaling has been previously implicated in both vascular and cardiac development in multiple vertebrate systems. In mouse, loss of Shh causes several cardiac abnormalities, including ventricular hypoplasia, septation defects and outflow tract shortening (Chiang et al., 1996; Tsukui et al., 1999) . Smo−/− mutant mice exhibit more severe cardiac defects, including aberrant cardiac morphogenesis, reduced heart size and delayed initiation of the early myocardial marker nkx2.5 expression (Zhang et al., 2001) . Vasculature of Ihh or Smo mutant murine yolk sacs fails to develop beyond a primitive vascular plexus and does not progress up to the angiogenic stage of development (Byrd et al., 2002) . Zebrafish Smo mutant embryos and cyclopamine-treated embryos do not form dorsal aorta and display inhibited migration and arterial differentiation of endothelial cells (Gering and Patient, 2005; Williams et al., 2010) . Recent studies show that Hh signaling is received cellautonomously within the endothelial cell progenitors during arterial differentiation (Williams et al., 2010) . Hh signaling has been also implicated in zebrafish myocardial formation since cyclopamine-treated embryos and Smo mutants have reduced number of cardiomyocytes (Thomas et al., 2008) . However, the role of Hh signaling in the formation of endocardium if any, remains unknown.
In this study we analyze the molecular pathways that regulate endocardium formation in zebrafish. We show that Hh signaling is essential for the endocardial progenitor specification and differentiation while VegfA and Notch function is dispensable for these processes. Genetic or pharmacological inhibition of Smo or Shh and Twhh function results in the nearly complete absence of endocardial progenitors while vascular endothelial differentiation is not affected. We further show that the endoderm is required for endocardial migration but not differentiation while the notochord is a likely source of the endocardial specification and differentiation signal which is received cell-autonomously by endocardial cells. These results argue that Hh signal is necessary for specification and differentiation of the endocardial progenitors.
Materials and methods
Zebrafish strains and staging
Wild-type Ekkwill (EK) strain and fn1 tl43c (AB) (natter) (Jiang et al., 1996; Trinh and Stainier, 2004) , shha t4 (AB) (sonic you) (Schauerte et al., 1998) , smo b641 (AB) (Barresi et al., 2000) ; clo m39 (Stainier et al., 1995) ; flh n1 (Talbot et al., 1995) ; mutant strains as well as Tg(fli1a: EGFP) y1 , Tg(cmlc2:mCherry) sd7 (Palencia-Desai et al., 2011) , Tg(etsrp:EGFP) ci1 (Proulx et al., 2010) transgenic strain were used in this study. All embryonic stages were determined based on the morphological staging criteria .
Chemical treatments
Cyclopamine (LC Laboratories) and N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (Sigma) was dissolved at a stock concentration of 10 mM in dimethylsulfoxide (DMSO). Embryos were manually dechorionated in 1× Danieau solution and placed into 100 μM of cyclopamine or 100 μM DAPT solution. To remove cyclopamine, embryos were washed 3 times in 1× Danieau solution.
In situ hybridization and overexpression constructs
In situ hybridization was performed as previously described (Jowett, 1999) . NFATc1 (Open Biosystems, cat no. EDR1052-9118306, accession no. CN320837) and fn1 (Open Biosystems, cat. no. EDR1052-96834665) cDNA clones, both in pExpress1 vector, were digested with EcoRI and transcribed with T7 RNA polymerase (Promega). flk1/kdrl (Thompson et al., 1998) ; fli1 (Thompson et al., 1998) ; cdh5 (Sumanas et al., 2005) ; ptc1 (Concordet et al., 1996) probes were synthesized as described. To overexpress shh and twhh RNA, shh-T7TS and twhh-T7TS constructs (Ekker et al., 1995) were linearized with BamHI and transcribed using T7 mMessage mMachine Kit (Applied Biosystems). 200 pg of shh and 200 pg of twhh RNA were injected per embryo.
Morpholinos
The following doses of MOs were used for injection: 7.4 ng shh MO (GCAGCACTCTCGTCAAAAGCCGCAT, Open Biosystems) + 2.2 ng p53 MO (Robu et al., 2007) ; 7.5 ng shh MO + 2 ng twhh MO (GCTTCAGATGCAGCCTTACGTCCAT, Open Biosystems) + 1 ng p53 MO; 10 ng smo MO1 (CGCTTGGAGGACATCTTGGA GACGC, Open Biosystems) + 3.2 smo MO2 (TGTTTCATCAAATGTTTCCA AATAA, Gene Tools) + 2 ng p53 MO; 7.5 ng sox32 MO (Dickmeis et al., 2001 ) (CAGGGAGCATCCGGTCGAGATACAT, Gene Tools) + 3 ng p53 MO; 10.5 ng VegfA MO . p53 MO was added to most MO mixtures to reduce toxic effects (Robu et al., 2007) . 3 ng of standard control MO (CCTCTTACCTCAGTTACAATTTATA, Gene Tools) and 3 ng of p53 MO were injected in control experiments.
Image capture and processing
For flat-mounting, yolk was manually removed and dehydrated embryos were flat-mounted in Araldite media. Alternatively, embryos were whole-mounted in 2% methylcellulose. 22 hpf and older embryos were mounted on glass slides in 2% methylcellulose. Images were captured using 5× or 10× objective on AxioImager Z1 (Zeiss) compound microscope with Axiocam ICC3 color camera (Zeiss). Images in different focal planes were combined using Extended Focus module within Axiovision software (Zeiss). Image levels were adjusted using Adobe Photoshop CS2 to increase the contrast.
Real-time RT-PCR analysis
Batches of 25 control uninjected and shh RNA-injected embryos were frozen on dry ice at 24 hpf stage. Total RNA was purified using the RNAquous-4PCR kit (Ambion). cDNA was synthesized using Superscript III reverse transcriptase and oligo-dT primer (Invitrogen). Real-time PCR was performed using Chromo4 thermal cycler (Bio-Rad) and iQ SYBR Green Supermix (Bio-Rad). The following PCR profile was used: 95°C 5 min; 95°C 1 min, 58°C 1 min, 72°C 1 min, detection at 82°C for 10 s; steps 2 through 5 repeated 44 times. Primer sequences used: NFATc1: GTGACGGAGGACAGTTGGTT; AGAGCAGGC AGTGATGGACT; EF1α: TCACCCTGGGAGTGAAACAGC; ACTTGCAGGCG ATGTGAGCAG. Relative cDNA amounts were calculated using the iCycler software (BioRad) and normalized to the expression of elongation factor 1α (EF1α).
Proliferation and apoptosis assays
Whole mount immunohistochemistry against phosphorylated histone H3 was performed as described previously (Shepard et al., 2004) . To perform anti-caspase staining, cyclopamine treated or control embryos were lightly fixed using 1% paraformaldehyde in 1× PBS for 1 h. Embryos were rinsed with PBS/0.2% Saponin and blocked with blocking solution (10% Sheep Serum/2 mg/ml BSA/0.2% (w/v) saponin in 1× PBS) for 1 h. Embryos were incubated overnight with rabbit anti-active caspase-3 (BD Pharmingen 559565) antibody (1:400) in blocking solution, briefly washed with PBS/0.2% Saponin and incubated in dark for 2 h with 1:400 secondary donkey anti rabbit igG-Alexa 594 (Invitrogen A21207). Secondary was washed off with PBS/0.2% Saponin and embryos were immediately flat mounted with Vector Vectashield (H-1000).
Transplantation
Donor Tg(fli1a:EGFP) y1 embryos were injected with smo MO mixture containing 1 mg/ml Tetramethyl Rhodamine Iso-Thiocyanate (TRITC)-dextran, Mw 2 × 10 6 (Invitrogen). Control donor Tg(fli1a: EGFP) y1 embryos were injected with 15 ng of random control MO (Gene Tools) and TRITC-dextran. Donor and wt recipient embryos were manually dechorionated. Approximately 100 cells were transplanted from control to recipient embryos by adjusting balance pressure of air pressure microinjector PLI-90 (Harvard Apparatus). Embryos were analyzed at 30-32 hpf for the presence and location of fli1a:EGFP fluorescent cells.
Results
NFATc1 expression specifically labels endocardium
At present, there are very few molecular markers known that are specifically expressed in endocardial progenitors during early stages of differentiation. One of them is NFATc1, expressed in endocardial but not vascular endothelial cells during early mouse development (de la Pompa et al., 1998) . To determine the expression of zebrafish NFATc1, we performed in situ hybridization analysis at different stages of early development using cDNA clone that corresponds to zebrafish NFATc1 homolog. Its earliest endocardial expression is apparent by 22 hpf and becomes more pronounced by 24-26 hpf (Figs. 1A-C). Strong NFATc1 expression is also apparent in the olfactory placodes while much fainter subepidermal expression is present bilaterally along the trunk, in the adaxial cells along the midline, in the most caudal part of the notochord and the tailbud (Fig. 1B) . Faint NFATc1 expression is also present within cranial vascular endothelial cells at 22 hpf ( Fig. 1A) . NFATc1 expression is absent from the heart region in the cloche mutants which have no endocardium (Stainier et al., 1995) (Figs. 1C,D) , which confirms that NFATc1 expression is indeed endocardial. NFATc1 expression is present throughout the endocardium at 32-48 hpf (Figs. 1E,F) while its expression in vascular endothelial cells is no longer apparent at these stages. By 72 hpf NFATc1 endocardial expression becomes restricted to the valve forming regions within the atrioventricular canal and the outflow tract (Figs. 1G,H). Its intense expression is also apparent in the olfactory placodes, and the cartilage of pharyngeal arches (Fig. 1G ).
Vegf and Notch signaling is dispensable for endocardial differentiation
Vegf, Hh and Notch signaling pathways have been previously implicated in different aspects of endothelial cell differentiation (Lawson et al., 2001 Williams et al., 2010) . However, their role in endocardial specification and differentiation has not been analyzed. To test if Vegf signaling is required for endocardium formation, endocardial NFATc1, cdh5, kdrl and fli1 expression was analyzed at the 18-somite-24 hpf stages in VegfA MO knockdown embryos. No significant defects in endocardial marker expression were observed in VegfA morphants compared to their uninjected controls (Figs. S1A-F, Table S1 and data not shown) while arterial marker expression was absent (Figs. S1G,H), as reported previously . Similarly, pharmacological inhibition of Notch signaling using γ-secretase inhibitor DAPT had no significant effect on the migration or differentiation of endocardial precursors (Figs. S2A-D, Table S2 ), while it resulted in the expansion of venous flt4 expression and defects in somitogenesis (Figs. S2E,F, and data not shown), as reported previously (Geling et al., 2002; Lawson et al., 2001) .
Pharmacological inhibition of Hh signaling results in the absence of differentiated endocardium
To assay the role of Hh signaling in endocardial development, embryos were incubated in 100 μM cyclopamine solution starting at the sphere stage (4 hpf, see Materials and methods). Subsequently, embryos were fixed at selected stages for endocardial marker expression analysis. Control embryos were incubated in 1% DMSO solution. Endocardial precursors in wild-type (wt) embryos migrate to the midline during the 15-16-somite stages while vascular endothelial precursors of the cranial vessels remain bilateral (Bussmann et al., 2007) . Kdrl and chd5 expression at the midline was greatly reduced in CyA-treated embryos at the 18-somite stage while bilateral expression of the two markers was not affected (Figs. 2A-D, Table S3 ). Endocardial kdrl and NFATc1 expression within the heart tube was absent or greatly reduced in CyA-treated embryos at 24-48 hpf stages (Figs. 2E-J, Table S3 ). As reported previously, CyA-treated embryos also display reduced myocardial cmlc2 expression (Figs. 2K,L) (Thomas et al., 2008) . Interestingly, by 48 hpf CyA-treated embryos have a reduced heart that fails to loop (Thomas et al., 2008) . Reduced endocardium is present in the hearts of CyA-treated embryos at 48 hpf, as observed in endocardial-specific Tg(etsrp:EGFP) ci1 and myocardial-specific Tg(cmlc2:mCherry) sd7 lines (Figs. S3A,B ). However, no NFATc1 expression is observed when the same transgenic embryos are assayed for its expression by in situ hybridization (Figs. S3C,D). These experiments argue that Hh signaling is required for the differentiation of endocardial progenitors as assayed by NFATc1 expression.
Shh, twhh and smo function is required for endocardium formation
We tested if genetic inhibition of Hh signaling would also result in similar defects in endocardium formation. Injection of a previously validated mixture of shh and twhh MOs resulted in a similar absence or strong reduction of endocardial kdrl and NFATc1 and myocardial cmlc2 expression (Figs. 3A-H, Table  S4 ). Similarly, MO knockdown of Hh co-receptor Smo resulted in similar endocardial and myocardial defects, as analyzed by kdrl and NFATc1 expression (Figs. 3I-P, Table S4 ). Because injection of either shh + twhh MO mixture or smo MO resulted in minor non-specific defects (data not shown), p53 MO was added to each MO mixture to prevent nonspecific activation of p53-mediated apoptosis pathway, commonly activated by MO injections, as described previously (Robu et al., 2007) . Both shh + p53 MOs and smo + p53 MOs phenocopied previously described morphological shh−/− and smo−/− zygotic mutant phenotypes , the most caudal part of the notochord and the tailbud (arrow). Lateral (the main panel) and dorsal views of the trunk and tail regions (inset). Endocardial expression is not apparent in these views. (C,D) Endocardial NFATc1 expression (arrow, C) is absent in clo−/− mutants (D) compared with their siblings in (C) as analyzed at 26 hpf. Approximately ¼ (16 out of 63) embryos obtained from heterozygous clo+/− carriers showed this phenotype. (E,F) NFATc1 expression throughout the endocardium at 32 hpf (E) and 48 hpf (F) (a, atrium; v, ventricle; arrow points to the atrioventricular boundary). (G,H) NFATc1 expression at 72 hpf includes the olfactory placodes (op) and pharyngeal arch skeleton (pa). NFATc1 is no longer expressed throughout the endocardium but is localized to the valve-forming regions in the atrioventricular canal (arrow, H) and the outflow tract (arrowhead, H). (Chen et al., 2001; Schauerte et al., 1998) , and no toxic effects were observed at the doses used. Standard control MO or p53 MO injection resulted in no apparent morphological defects and did not affect endocardial or myocardial development (Figs. S4, S5). NFATc1 expression was downregulated but still apparent in smo−/− zygotic mutant embryos (Figs. 3Q,R, Table S5 ). It has been reported that smo displays strong maternal expression (Chen et al., 2001) , which is a likely reason why smo zygotic mutant phenotype is less severe than MO knockdown. Mild reduction of endocardial NFATc1 expression was also observed in shh−/− mutant embryos (Figs. 3S,T, Table S5 ). The phenotype is not as severe as with the double shh/twhh MO injection likely because of partially redundant role between shh and twhh homologs in endocardium formation.
Hh signaling is required between 10 hpf and 16.5 hpf stages for endocardial morphogenesis
To determine the temporal window for Hh requirement in endocardium formation, cyclopamine was added or removed at different stages of development. Addition of cyclopamine at the 10-somite stage (14 hpf) or earlier resulted in the majority of embryos showing nearly complete loss of endocardial NFATc1 and kdrl expression (Figs. 4A,C). However, treatment at the 15-somite stage (16.5 hpf) resulted in the majority of embryos showing still significant but less severe reduction in NFATc1 expression (Figs. 4A,C, Table S6 ). Interestingly, these embryos only showed minor reduction in kdrl expression which suggests that Hh signaling is required at later stages for endocardial differentiation (NFATc1 expression) than specification (kdrl expression). Most of the embryos treated at the 20-somite stage (19 hpf) and later displayed mild or no reduction in NFATc1 or kdrl expression (Figs. 4A,C, Table S6 ). These data indicate that Hh signaling is required until the 15-somite (16.5 hpf) stage while at later stages it only plays minor if any role in endocardial morphogenesis.
To determine the starting point for Hh signaling requirement, embryos were treated with CyA starting at the sphere stage (4 hpf) and CyA was washed out at different developmental stages. CyA removal 1-1.5 h later at the 30-50% epiboly stages resulted in no significant defects in endocardium formation which demonstrates that CyA can be effectively removed with this method (Fig. 4B ). Embryos that were removed from CyA solution at the tailbud stage (10 hpf) showed a significant reduction in NFATc1 and kdrl expression while removal at the 5-somite stage (11.5 hpf) and later resulted in strong reduction or nearly complete loss of the endocardial staining (Figs. 4B,D, Table S7 ). These data argue that Hh signaling is required from the tailbud until the 15-somite stages (10-16.5 hpf) for endocardial morphogenesis. In a control experiment, CyA-treatment effectively inhibited expression of Hh target gene ptc1, and CyA could be efficiently washed out after incubating embryos for 1.5 h in the CyA solution (Figs. S6A-C). Furthermore, incubation for only 2.5 h in CyA solution from the 19-somite to the 25-somite stages was sufficient to effectively inhibit ptc1 expression (Figs. S6D-F).
Previous studies have demonstrated Hh requirement for myocardial morphogenesis (Thomas et al., 2008) . It is possible that Hh signaling is required independently for both myocardial and endocardial morphogenesis or, alternatively, observed endocardial defects may be a secondary consequence due to perturbed myocardial morphogenesis. Previous studies have defined the temporal window for Hh requirement in myocardial morphogenesis, between the germ ring and the 10-somite stage (Thomas et al., 2008) . We tested if treating at a later stage may selectively affect endocardial morphogenesis. Indeed, CyA addition at the 15-somite stage resulted in significant inhibition of endocardial NFATc1 expression but had little if any effect on myocardial cmlc2 expression ( Fig. 5, Table S8 ). These results argue that Hh signaling has independent roles in endocardial and myocardial morphogenesis.
Hh overexpression perturbs endocardial morphogenesis
To test if Hh signaling is sufficient for endocardial specification, synthetic shh or twhh RNA was microinjected into zebrafish embryos. Overexpression of either shh or twhh RNA resulted in specific defects that included reduction or loss of lens and retinal fates, as reported previously (data not shown) (Ekker et al., 1995) . NFATc1-expressing endocardial precursors in shh or twhh RNA injected embryos were present in the wide area in the cardiac forming region close to the midline but did not coalesce into the cardiac tube (Fig. 6 ). Based on quantitative RT-PCR, normalized NFATc1 expression at 24 hpf in shh RNA injected embryos was not significantly different from uninjected controls (shh RNA vs. control ratio was 0.79 ± 0.16 for 50 pg shh RNA dose and 1.12 ± 0.17 for 150 pg). This shows that Hh overexpression perturbs endocardial morphogenesis but is not sufficient to induce ectopic endocardial differentiation. Fibronectin expression in the endocardial precursors requires Hh signaling Fibronectin (fn1) is an extracellular matrix protein, necessary for the migration of cardiomyocytes. It is thought to be secreted by the endocardial cells in both mammalian and zebrafish embryos and is the earliest currently known marker expressed in the endocardial but not vascular-endothelial progenitors (George et al., 1997; Palencia-Desai et al., 2011; Suzuki et al., 1995; Trinh and Stainier, 2004) . Its expression was greatly reduced in CyA-treated embryos as early as the 10-somite stage, well before the migration of endocardial precursors to the midline (Figs. 7A,B , Table S9 ). Similar reduction in fn1 expression was also observed at the 14-somite and 18-somite stages (Figs. 7C-F) . Fn1 expression was also reduced in shh + twhh MO and smo MO-injected embryos (Figs. 7G-J, Table S9 ). These results argue that Hh signaling affects endocardial fn1 expression as early as the 10-somite stage, suggesting that Hh is involved in the earliest stages of endocardial specification.
Because the loss of fn1 expression in the endocardial precursors is the earliest endocardial defect observed in CyA-treated embryos, we considered a possibility that the absence of fn1 function may be responsible for the later defects in endocardial morphogenesis. However, as reported in a recent study, endocardial progenitors do migrate to the midline in the natter/fn1 genetic mutants where they form a dismorphic sheet (Garavito-Aguilar et al., 2010) (Figs. 7K,L). Interestingly, NFATc1 expression was nearly completely absent in nat mutants while kdrl expression appeared to label a severely reduced heart tube that is mislocalized and forms abnormal vascular connections (Figs. 7M-P, Table S5 ). Fn1 expression was nearly completely absent in nat mutants which prevented us from analyzing the presence and location of fn1-expressing progenitors (data not shown). Therefore while fn1−/− mutants and CyA-treated embryos share some similarities in endocardial defects, the two phenotypes are distinct, and the loss of endocardial fn1 expression cannot fully account for all of the endocardial defects observed in Hh-inhibited embryos.
Time-lapse imaging of endocardial precursor migration in Hh-inhibited embryos
In an attempt to determine the fate of the endocardial precursors in CyA-treated embryos, we performed time-lapse imaging in Tg (etsrp:EGFP) ci1 transgenic line. While there is currently no reporter line which would label exclusively endocardial progenitors at these early stages, Tg(etsrp:EGFP) is one of the earliest reporters which displays strong expression in the endocardial progenitors, as well as vascular endothelial and myeloid cells which all originate in the ALPM region (Proulx et al., 2010) . As we and others have reported previously, endocardial progenitors originate in the midbrainorganizing center (MOC) within the ALPM, which also gives rise to the cranial vascular endothelial and myeloid progenitors (Proulx et al., 2010; Schoenebeck et al., 2007) . Since it was not possible to image CyA-treated embryos under standard treatment conditions, because embryos had to be removed and mounted in the agarose for extended time periods, during which they showed significant recovery of endocardial defects, we imaged CyA-treated embryos that were injected with Smo MO. This "double" inhibition of Hh signaling resulted in reproducible defects in endocardial morphogenesis, similar to the ones observed under standard CyA-treated conditions. No Endocardial kdrl expression appears to be mislocalized and reduced in fn1/nat mutants at 32 hpf. Note that while the arrow points to the presumptive endocardial tube in nat mutants (P), it is not possible to reliably distinguish endocardial from vascular endothelial cells based on kdrl expression alone. All panels, ventral view of flat-mounted embryos, anterior is up. Individual nat mutant embryos were genotyped at the 18-somite stage following in situ hybridization as described previously (Garavito-Aguilar et al., 2010) , while at older stages they were separated based on their morphological phenotypes.
other non-specific defects were observed. The initial MOC formation proceeded normally in Hh-inhibited embryos and no apparent defects were observed at the 10-12-somite stages (Fig. S7, 0 min, Suppl. Movies 1, 2). We have also quantified Tg(etsrp:EGFP)-expressing cells in the MOC region in fixed flat-mounted embryos, and there was no significant difference between the Hh-inhibited and control embryos (Table S10 ). However, as the endocardial cells migrated towards the midline in wt embryos at the 14-15-somite stages, such migration was notably absent in Hh-inhibited embryos (Fig. S7, 80-120 min) . Quantification of Tg(etsrp:EGFP) cells in DMSO control and CyA-treated embryos at the 16-17-somite stages showed that the midline population of GFP cells was significantly reduced while the numbers of bilaterally located cells that normally correspond to the cranial endothelial progenitors were not affected (Table S10 ). Interestingly, the total number of GFP positive cells was smaller in Hh-inhibited embryos suggesting either defective cell proliferation, specification or increased apoptosis among endocardial progenitors.
Hh signaling promotes proliferation of endocardial progenitors
To determine if Hh signaling may regulate proliferation of endocardial progenitors, we performed immunostaining against phospho-Histone H3 in etsrp:GFP transgenic CyA-treated and control DMSOtreated embryos. Z-stacks of flat-mounted embryos were analyzed for an overlap of GFP fluorescence and phospho-H3 immunostaining in each section within the MOC region at the 12-13-somite stages. A significant reduction in proliferating Tg(etsrp:EGFP) cells within the MOC region was observed in CyA-treated embryos (Fig. 8) . DMSO treated embryos had an average of 5.5 proliferating cells per embryo while CyA-treated embryos had only 2.5 (p= 0.01). We also assessed cell proliferation in the neural region which was not affected in CyA-treated Fig. 8 . Proliferation of endocardial progenitors is reduced in CyA-treated embryos compared to DMSO-treated controls. Maximum projection images of Tg(etsrp:EGFP) fluorescence (left), phospho-histone staining (right) and overlap of the two channels (middle) are shown. Ventral views of flattened deyolked embryos at the 13-somite stage, anterior is to the top. Formation of the midbrain-organizing center (MOC, arrows) which gives rise to many cranial endothelial, endocardial and myeloid progenitors is not significantly affected in CyA-treated embryos. However, phospho-histone staining within the MOC region (arrowheads) is significantly reduced in CyA-treated embryos. Note that because the presented view is the maximum projection image, staining in some cells may appear to overlap while they are actually present in different focal planes. Left graph shows average cell count per embryo of phospho-histone stained Tg(etsrp:EGFP) cells in the MOC region which is significantly different between DMSO and CyA-treated embryos. As shown in the right graph, the number of neural progenitors scored in a randomly selected area is not significantly different between the DMSO and CyA-treated embryos. embryos. Because Tg(etsrp:EGFP) expression labels not only endocardial but also vascular endothelial and myeloid lineages, it is possible that proliferation defects are not restricted to the endocardial lineage. However, these results argue that Hh signaling promotes proliferation of Tg (etsrp:EGFP)-expressing cells in the ALPM region that include the endocardial progenitors.
To determine if CyA treatment results in increased apoptosis of endocardial progenitors, anti caspase staining was performed in the control and CyA-treated Tg(etsrp:EGFP) embryos at the 14-15-somite stages. No statistically significant difference in the numbers of apoptotic Tg(etsrp:EGFP)-positive cells within the MOC region was observed (Suppl. Fig. S8 ).
Notochord is required for endocardial differentiation
Shh expression is observed in the notochord and the floorplate, while twhh expression is observed in the hypochord during the somitogenesis stages (Ekker et al., 1995; Krauss et al., 1993) . In addition, shh expression has been observed in the endoderm at 26 hpf and later stages (Reichenbach et al., 2008) . Therefore the notochord/floorplate and the endoderm are the two likely sources of the Hh signal. Floating head (flh) mutants display strong reduction in the number of notochordal cells and strong downregulation of notochordal and floorplate shh expression (Strahle et al., 1996; Talbot et al., 1995) .
To determine if the notochord and the floorplate may be the sources of the endocardial induction signal, we analyzed endocardial marker expression in flh mutants. Significant reduction in fn1, kdrl and NFATc1 expression was observed in flh mutants (Fig. 9, Table S5 ). While the numbers of endocardial progenitors were reduced, their migration and coalescence into the heart tube did not appear significantly affected. Flh mutants display only partial reduction of shh expression in the anterior floorplate (Talbot et al., 1995) , which may explain incomplete loss of endocardial marker expression. Thus the notochord/floorplate have at least partial requirement for the endocardial morphogenesis.
Endoderm is required for endocardial progenitor migration but not differentiation
It has been previously reported that endodermal mutants such as sox32 have defective migration of myocardial precursors and display split myocardial fields however their differentiation appears unaffected (Alexander et al., 1999; Kupperman et al., 2000) . While it has been observed that endocardial precursors do not migrate to the midline in the absence of endoderm (Holtzman et al., 2007) , their differentiation status has not been previously examined. To knockdown sox32 function, we used a previously validated sox32 MO which results in the nearly complete absence of the endoderm (Dickmeis et al., 2001) . Bilateral fn1 expression within the presumptive endocardial progenitors was not affected in sox32 morphants at the 12-somite stage (Figs. 10A,B , Table S11 ). However, fn1-expressing endocardial progenitors failed to migrate towards the midline and remained localized bilaterally at the later somitogenesis stages (Figs. 10C,D) . Similarly, endocardial/ endothelial kdrl and cmlc2 expression remained split bilaterally (Figs. 10E-H,K,L, Table S11 ), as previously reported (Holtzman et al., 2007) . Interestingly, sox32 morphants display bilaterally split NFATc1 expression at 26 hpf (Figs. 10I,J) . These results argue that migration of endocardial progenitors towards the midline is not required for their differentiation and that the two steps in endocardial morphogenesis are independently regulated. These results also show that the endoderm is required for the migration of endocardial progenitors but is dispensable for their differentiation.
Smo function is required cell-autonomously within endocardial progenitors
To test if Hh signaling is received cell-autonomously by the endocardial progenitors, mosaic analysis was performed using smo MOinjected embryos. Smo morphants display strong reduction in endocardial differentiation and NFATc1 expression. Approximately 50-100 cells from each embryo were transplanted at the sphere stage from smo MO-injected Tg(fli1a:EGFP) y1 transgenic embryos into wt recipients. To control for the effectiveness of transplantation, smo MO solution also contained TRITC-dextran. The recipient embryos were analyzed at 30-32 hpf for the presence of fli1a:GFP cells. Although fli1a is expressed in both vascular endothelial and endocardial cells, endocardial fli1a expression can be easily recognized by their location within the beating heart. Because only donor embryos are transgenic for Tg(fli1a:EGFP), any GFP cells present in the endocardium would be also defective in smo function. At the same time, control Tg(fli1a: EGFP) embryos were injected with the same concentration of control MO and TRITC-dextran mixture, and similar numbers of cells were transplanted into wt embryos. Averaged from 11 independent experiments, 7.1% of control embryos and 3.1% of smo MO transplants displayed endocardial Tg(fli1a:EGFP) cells (Fig. 11, Table S12 ). This shows that smo morphant cells contribute to the endocardium at a significantly lower rate than the control cells (p= 0.036). Among the embryos that had any Tg(fli1a:EGFP) cells within the endocardium, the majority of them (95% of control and 92% of smo morphant embryos) contained only a single GFP-positive cell (Table S12 ). Importantly, there was no reduction in the contribution of smo MO cells to vascular endothelium; 73.8% of control embryos and 77.8% of smo MO transplants displayed endothelial expression. These results argue that smo morphant cells can successfully contribute to vascular endothelial but not endocardial lineage which indicates that Smo function is required cell-autonomously within the endocardial progenitors.
Discussion
In this study, we show that Hh signaling is required for the earliest steps of specification and differentiation of the endocardial progenitors in a zebrafish embryo. In addition, Hh signaling promotes proliferation of early endocardial progenitors. Furthermore, we show that Hh signaling is received cell autonomously by the endocardial progenitors, and the notochord is a likely source of Hh signal while the endoderm is necessary for endocardial migration but is dispensable for endocardial differentiation.
Hh role in endocardial proliferation, specification and differentiation
Because fn1 is the earliest marker associated with endocardial development, initiation of its expression may represent endocardial specification. Interestingly, fn1 mutants display some similarities to Hh-inhibition phenotype such as the absence of NFATc1 expression. However, fli1+ and kdrl + cells that presumably represent endocardial precursors still migrate to the midline in nat/fn1−/− embryos (Garavito-Aguilar et al., 2010) . Therefore the absence of fn1 expression alone is insufficient to explain endocardial migration defects observed in Hh-inhibited embryos. It is possible that Hh serves merely as a permissive factor and induces expression of additional genes within the endocardial progenitors required for their migration. However, we cannot exclude a possibility that Hh serves as a chemoattractant itself for the endocardial progenitor migration. Furthermore, our results suggest that Hh requirement for endocardial differentiation is separate from its role in endocardial specification. In support to this argument, CyA-treated embryos display endocardial Tg(etsrp:EGFP) by 48 hpf while NFATc1 expression is mostly absent. These results suggest that Hh signaling is independently required for endocardial progenitor specification and differentiation.
Our results show that proliferation of Tg(etsrp:EGFP)-positive cells which include endocardial progenitors, is significantly reduced in Hhinhibited embryos. Hh is a known mitogen and cell survival factor (Ingham and McMahon, 2001) . Its downstream targets include cell cycle regulators such as cyclins D1, E and n-myc (Kenney and Rowitch, 2000; Oliver et al., 2003) . Hh signaling has been previously implicated in the proliferation of the secondary heart field progenitors in chick embryos (Dyer and Kirby, 2009 ). An important question is whether the defects in endocardial specification and differentiation observed in Hh-inhibited embryos, are merely a consequence of inhibition of endocardial proliferation. If endocardium originates from a small pool of progenitors that subsequently undergo proliferation, then inhibition of proliferation would result in greatly reduced numbers of differentiated endocardial cells. However, our results argue against such model. During cell transplantation experiments using Tg(fli1a:GFP)-positive cells derived from control embryos, among the transplanted embryos that showed any Tg(fli1a:GFP)-positive cells within the endocardium, the majority of them contained only a single GFP-labeled cell. If the endocardium was derived from a small pool of proliferating progenitors, then the majority of GFP-positive embryos would contain multiple GFP-positive cells within the endocardium. This suggests that there is very little if any proliferation among the endocardial progenitors after the specification stage until the time of analysis (32 hpf). One likely explanation for these results is that Tg(etsrp:EGFP) progenitors proliferate within the MOC region prior to the endocardial specification. Only some of the Tg(etsrp: EGFP) progenitors will commit to the endocardial fate, mostly after proliferation is complete while other cells may contribute to the vascular endothelial and/or myeloid lineages. Therefore if transplanted cells become localized to the MOC region and proliferate, only a fraction of their progenitors will contribute to the endocardium. Hhinhibited embryos then display reduced proliferation of Tg(etsrp: EGFP) progenitors prior to their commitment to the endocardial lineage. Our data also cannot exclude the possibility that while most endocardial progenitors do not proliferate after endocardial specification, there is a small pool of highly proliferative progenitors which may be difficult to target in transplantation experiments but which may account for a significant portion of the endocardial growth.
Requirement for Hh signaling in endocardial and myocardial morphogenesis
Interestingly, although endocardial and vascular endothelial cells share expression of multiple markers and may originate from a common precursor, endocardial development is not affected by Vegf and Notch signals that regulate endothelial differentiation. Instead, based on our and previous studies, both endocardial and myocardial progenitors require Hh signal for proper morphogenesis (Thomas et al., 2008) . It has been shown previously that both BMP and Wnt signals are also similarly required for endocardial and myocardial differentiation in vitro (Misfeldt et al., 2009) . Therefore it appears that similar signals may induce specification of both endocardial and myocardial lineages. Since both myocardial and endocardial progenitors develop in close vicinity, an important question is whether Hh signaling is directly received by the endocardial progenitors or whether endocardial defects in Hh-inhibited embryos can be indirect consequence of inhibited myocardial morphogenesis. Several lines of evidence argue that Hh role in endocardial morphogenesis is independent from its myocardial role. Hedgehog affects fn1 expression in endocardial progenitors as early as the 10-somite stage, when endocardial progenitors are positioned more rostrally to the myocardial cells within the ALPM and the majority of endocardial and myocardial cells are not in direct contact. Second, the time interval of Hh requirement for endocardial morphogenesis, between the tailbud and the 15-somite stages, is different from its previously established requirement in myocardial morphogenesis, between the germ ring and the 10-somite stage (Thomas et al., 2008) . As we show in the current study, embryos treated with CyA at the 15-somite stage, show only defects in endocardial but not myocardial morphogenesis. And finally, mosaic analysis using Smo morphants argues that Hh signal is received directly within endocardial progenitors. Therefore Hh signaling appears to have two independent roles in endocardial and myocardial development.
Potential sources of Hh signaling
Knockdown of shh alone has only minor effect on endocardial formation, while simultaneous knockdown of shh and twhh results in the nearly complete absence of endocardial markers. This argues that Shh and Twhh function redundantly during endocardial morphogenesis. The potential sources for Hh signal are the notochord, floorplate and the hypochord where Shh and Twhh expression is observed, and the endoderm (Ekker et al., 1995; Krauss et al., 1993; Reichenbach et al., 2008) . Although endodermal Hh expression has not been observed prior to 26 hpf, low amounts of Hh cannot be excluded. Flh mutants display nearly complete loss of notochordal cells and strongly reduced or lost shh and twhh expression in the notochord and the floorplate (Du and Dienhart, 2001; Strahle et al., 1996; Talbot et al., 1995) . Flh mutants display significant reduction in the endocardial marker expression which supports the hypothesis that notochordal and floorplate-derived Shh and Twhh induce endocardial differentiation. Although significant NFATc1 expression is still present in flh mutants this can be explained by only mild reduction in shh expression within the anterior neural plate observed in flh mutants (Talbot et al., 1995) . Alternatively, there could be another source of Hh signal. Importantly, the endoderm is required for migration but dispensable for differentiation of endocardial progenitors, similar to its requirement in migration of myocardial progenitors. These findings argue that endocardial progenitor migration and differentiation are regulated independently.
Evolutionary conservancy of Hh and Vegf signaling
An important question is whether the mechanisms of endocardial specification and requirement for Hh signaling are evolutionarily conserved between zebrafish and mammalian embryos. Fate mapping experiments in avian and zebrafish embryos have argued that endocardial and myocardial populations separate during early gastrulation stages, and a single labeled progenitor gave rise to either endocardial or myocardial cells but never both (Cohen-Gould and Mikawa, 1996; Lee et al., 1994; Milgrom-Hoffman et al., 2011; Wei and Mikawa, 2000) . In contrast, Cre-based fate mapping approaches in mouse embryos showed that the progeny of labeled cells was observed in both endocardial and myocardial lineages (Cai et al., 2003; Verzi et al., 2005) , although recent data suggest that mammalian endocardium may have heterogenous origins and at least some endocardial cells do not share a common origin with myocardial progenitors (Milgrom-Hoffman et al., 2011) . In vitro studies have shown that the progeny of a single flk1+ cardiovascular progenitor can contribute to myocardial and vascular endothelial/endocardial lineages (Kattman et al., 2006; Misfeldt et al., 2009) . It is possible that zebrafish cardiovascular lineages develop differently from mammalian and the common myocardial-endocardial progenitors exist only in mammalian and not zebrafish or avian development. However, no single cell fate mapping has been performed in mammalian embryos so far. Therefore, it is possible that Crereporters independently mark two distinct cell populations which originate from distinct progenitors (Harris and Black, 2010) . Recent studies show that both zebrafish and mouse endothelial-endocardial cells retain developmental plasticity and can be reprogrammed into myocardial cells in the absence of Etsrp/Etv2 function (Palencia-Desai et al., 2011; Rasmussen et al., 2011; Schoenebeck et al., 2007) . It is quite plausible that in both zebrafish and mammalian embryos endocardial and myocardial cells are derived from multipotent progenitors which retain developmental plasticity for a prolonged time. However, during normal development, these endocardial and myocardial progenitors are spatially separated and are derived from distinct subpopulations of these progenitors.
Previous studies have implicated Hh signaling in myocardial development both in mammalian and fish embryos. Thus myocardialspecific markers are downregulated in Smo−/− knockdown mice and Hh-inhibited zebrafish embryos (Thomas et al., 2008; Zhang et al., 2001) . This suggests that the role of Hh signaling in cardiac development may be evolutionarily conserved. While it appears that endocardium may be present in mouse Smo−/− or Shh/Ihh−/− mutant embryos, endocardial differentiation in these embryos has not been previously analyzed in greater detail, to our knowledge. Our results show that zebrafish Hh-inhibited embryos, similar to mouse Smo−/− or Shh/Ihh−/− embryos, do form dysmorphic endocardium at later stages, however, nfatc1 expression is greatly downregulated. Evolutionary conservancy for this Hh requirement still needs to be tested in future experiments.
Mouse VegfA and Flk1 knockout embryos show early defects of yolk sac vasculogenesis (Carmeliet et al., 2009; Ferrara et al., 1996; Shalaby et al., 1995) . Tie2Cre; Flk1 null mouse mutants lack both endothelial and endocardial cells which argues that Vegf-Flk1 signaling is required for both endothelial and endocardial development (Milgrom-Hoffman et al., 2011) . However, because overall early endothelial development is defective, it is hard to determine if VegfA has a specific requirement in early endocardial morphogenesis. Interestingly, hypomorphic VegfA knock-in allele shows no apparent defects in endocardial morphogenesis while blood vessel formation is greatly abnormal (Damert et al., 2002) . Similarly, our results suggest that zebrafish VegfA knockdown embryos do not show major defects in early endocardial morphogenesis while they display defects in vascular development. It is quite possible that VegfA MO knockdown cannot fully eliminate Vegf function, therefore this phenotype is hypomorphic and appears very similar to the mouse hypomorphic phenotype. In addition, VegfA in zebrafish may function redundantly with other Vegf homologs such as VegfAb and VegfC. Therefore our results cannot fully exclude requirement for Vegf signaling during early endocardial morphogenesis and suggest that the role for both Vegf signaling may not be that different between mammalian and zebrafish embryos.
In summary, our study identifies Hh as a key signaling pathway which is involved in the specification and differentiation of zebrafish endocardial progenitors. Cardiac morphogenesis and differentiation, including the endocardial NFATc1 expression pattern are highly conserved between zebrafish and mammalian embryos. Therefore our results will be important for understanding molecular mechanisms of cardiac morphogenesis which are related to multiple congenital heart defects in humans.
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